Media Summary: As chairman and executive director of the John Theurer Cancer Center, and chief of the Lymphoma Division, I am optimistic about ...

Dr Andre Goy On Future - Detailed Analysis & Overview

As chairman and executive director of the John Theurer Cancer Center, and chief of the Lymphoma Division, I am optimistic about ...

Photo Gallery

Dr. Andre Goy on Future Treatments for Patients With Diffuse Large B-Cell Lymphoma
Dr. Goy on Future Treatment Approaches in MCL
Dr. Goy on Future Agents in Lymphoma
Dr. Andre Goy at "What's Next? How to get busy living!"
Dr Andre Goy Discusses Potential Benefits of Earlier Use of CAR T Therapies
Dr. Andre Goy, MD speaks on precision medicine for the 4th Annual Precision Medicine Symposium
Dr. Goy on the Upcoming Conference at John Theurer Cancer Center
Dr. Andre Goy Invites you to the 25th Annual International Congress on Hematologic Malignancies
Doctors Who Make a Difference | Dr. Andre Goy, M.D. | Oncologist
Dr. Goy on the Significance of Becoming an NCI-Designated Cancer Center
Dr. Goy on John Theurer Cancer Center Milestone
Dr. Goy on Takeaways in Mantle Cell Lymphoma for the Future
View Detailed Profile
Dr. Andre Goy on Future Treatments for Patients With Diffuse Large B-Cell Lymphoma

Dr. Andre Goy on Future Treatments for Patients With Diffuse Large B-Cell Lymphoma

Andre Goy

Dr. Goy on Future Treatment Approaches in MCL

Dr. Goy on Future Treatment Approaches in MCL

Andre Goy

Dr. Goy on Future Agents in Lymphoma

Dr. Goy on Future Agents in Lymphoma

Andre Goy

Dr. Andre Goy at "What's Next? How to get busy living!"

Dr. Andre Goy at "What's Next? How to get busy living!"

Dr

Dr Andre Goy Discusses Potential Benefits of Earlier Use of CAR T Therapies

Dr Andre Goy Discusses Potential Benefits of Earlier Use of CAR T Therapies

Andre Goy

Dr. Andre Goy, MD speaks on precision medicine for the 4th Annual Precision Medicine Symposium

Dr. Andre Goy, MD speaks on precision medicine for the 4th Annual Precision Medicine Symposium

Update from program chair,

Dr. Goy on the Upcoming Conference at John Theurer Cancer Center

Dr. Goy on the Upcoming Conference at John Theurer Cancer Center

Andre Goy

Dr. Andre Goy Invites you to the 25th Annual International Congress on Hematologic Malignancies

Dr. Andre Goy Invites you to the 25th Annual International Congress on Hematologic Malignancies

Register now at: gotoper.com/go/HEM21.

Doctors Who Make a Difference | Dr. Andre Goy, M.D. | Oncologist

Doctors Who Make a Difference | Dr. Andre Goy, M.D. | Oncologist

Discover

Dr. Goy on the Significance of Becoming an NCI-Designated Cancer Center

Dr. Goy on the Significance of Becoming an NCI-Designated Cancer Center

Andre Goy

Dr. Goy on John Theurer Cancer Center Milestone

Dr. Goy on John Theurer Cancer Center Milestone

Andre Goy

Dr. Goy on Takeaways in Mantle Cell Lymphoma for the Future

Dr. Goy on Takeaways in Mantle Cell Lymphoma for the Future

Andre Goy

Dr. Goy Explains the Concept of Personalized Medicine

Dr. Goy Explains the Concept of Personalized Medicine

Andre Goy

Dr. Andre Goy Highlights Research From the 2012 ASCO Meeting

Dr. Andre Goy Highlights Research From the 2012 ASCO Meeting

Andre Goy

Dr. Andre Goy on Crizotinib for ALK-positive Pediatric Patients With ALCL

Dr. Andre Goy on Crizotinib for ALK-positive Pediatric Patients With ALCL

Andre Goy

Andre Goy, M.D., MS, leads a nationally recognized cancer center

Andre Goy, M.D., MS, leads a nationally recognized cancer center

Dr

Dr. Goy on Need for Payment Model for CAR T-Cell Therapy

Dr. Goy on Need for Payment Model for CAR T-Cell Therapy

Andre Goy

Regional Cancer Care Center’s Dr. Andre Goy on the Challenges of Treating Hodgkin’s Lymphoma

Regional Cancer Care Center’s Dr. Andre Goy on the Challenges of Treating Hodgkin’s Lymphoma

Dr

Dr Andre Goy Discusses What We’ve Learned About CAR T Therapies and Cytokine Responses

Dr Andre Goy Discusses What We’ve Learned About CAR T Therapies and Cytokine Responses

Andre Goy

Dr. Andre Goy - Doximity

Dr. Andre Goy - Doximity

As chairman and executive director of the John Theurer Cancer Center, and chief of the Lymphoma Division, I am optimistic about ...